Bon launches ai-powered new drug research and development

Xi'an, china , july 30, 2025 /prnewswire/ -- bon natural life limited (nasdaq: bon) ("bon" or "the company"), a leading provider of bio-ingredient solutions for the natural health and personal care industries, today announced the official launch of its ai-driven drug research and development (r&d) business. leveraging its extensive library of natural compounds - many derived from traditional chinese medicine (tcm) - the company will apply artificial intelligence algorithms to identify high potential lead compounds, marking a significant evolution in its pharmaceutical strategy.
BON Ratings Summary
BON Quant Ranking